ImageneBio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA
IMA chart
What traders are saying about $IMA
Latest postsImageneBio, Inc. news
- ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
Yahoo Finance ·
- ImageneBio Reports Second Quarter 2026 Financial Results
Yahoo Finance ·
- ImageneBio Appoints Matt Robbins as General Counsel
Yahoo Finance ·
- ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
Yahoo Finance ·
- ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
Yahoo Finance ·
- ImageneBio Announces $30 Million Private Placement
Yahoo Finance ·
- Imax announces $28M opening weekend for Amazon/MGM/s ‘Project Hail Mary’
Yahoo Finance ·
- ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer
Yahoo Finance ·
- ImageneBio Insider Confidence Rewarded, Stock Hits US$76m Market Cap
Yahoo Finance ·
- Here's Why We're Watching ImageneBio's (NASDAQ:IMA) Cash Burn Situation
Yahoo Finance ·
ImageneBio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $800,000 | $3.5M | $9.2M | $15.6M |
| Net income | -$45.3M | -$36.6M | -$68.2M | -$68.8M |
| Diluted EPS | $-9.64 | $-22.10 | $-1.63 | $-1.90 |
| Total assets (year end) | $153.0M | $15.9M | $192.1M | $172.3M |
| Cash and equivalents (year end) | $94.5M | $12.1M | $119.9M | $59.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About ImageneBio, Inc.
- Ticker
- IMA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1835579
- Former names
- Ikena Oncology, Inc.
Frequently asked questions
What exchange is ImageneBio, Inc. listed on?
ImageneBio, Inc. trades on the Nasdaq under the ticker symbol IMA.
What industry is ImageneBio, Inc. in?
ImageneBio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is ImageneBio, Inc. headquartered?
ImageneBio, Inc.'s business address on file with the SEC is in San Diego, CA.
When does ImageneBio, Inc.'s fiscal year end?
ImageneBio, Inc.'s fiscal year ends on December 31.
How much revenue did ImageneBio, Inc. report?
ImageneBio, Inc. reported $800,000 in revenue for calendar year 2025, according to its SEC filings.